CyclophosphamideDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsEtoposideAntineoplastic Agents, AlkylatingPhosphoramide MustardsVincristineMethotrexateCombined Modality TherapyDrug Administration ScheduleAntibodies, Monoclonal, Murine-DerivedPrednisolonePrednisoneLymphoma, Non-HodgkinLomustineBleomycinRemission InductionTreatment OutcomeAntineoplastic Agents, PhytogenicEpirubicinImmunosuppressive AgentsDisease-Free SurvivalVinblastineAntineoplastic AgentsPulse Therapy, DrugVinca AlkaloidsMelphalanSurvival AnalysisThiotepaLymphoma, Large B-Cell, DiffuseIfosfamideSurvival RateLeukopeniaBusulfanGranulocyte Colony-Stimulating FactorDose-Response Relationship, DrugDrug ResistanceBreast NeoplasmsFluorouracilCytarabineCarmustineCisplatinTransplantation, AutologousDexamethasoneVidarabineChlorambucilBone Marrow TransplantationMitoxantroneLeukemia P388Chemotherapy, AdjuvantRhabdomyosarcomaHodgkin DiseaseAsparaginaseP-GlycoproteinMesnaCarcinoma, Small CellTime FactorsHematopoietic Stem Cell TransplantationWhole-Body IrradiationDaunorubicinMethylprednisolonePrecursor Cell Lymphoblastic Leukemia-LymphomaFollow-Up StudiesNeoplasm StagingRecurrenceNeutropeniaMultiple MyelomaDactinomycinCystitisPaclitaxelDrug Resistance, MultiplePrognosisAdministration, MetronomicLymphoma, FollicularVindesineLeukemia L1210CarboplatinDrug Therapy, CombinationTeniposideDacarbazineTransplantation ConditioningLymphomaAntibiotics, AntineoplasticDrug Resistance, NeoplasmSemustineInfusions, IntravenousImmunosuppressionAzathioprineWegener GranulomatosisSarcoma, EwingThrombocytopeniaLupus NephritisLymphoma, B-CellAlkylating AgentsAntibodies, MonoclonalPodophyllotoxinLeukemia, LymphoidDrug SynergismActuarial AnalysisClinical Trials as Topic